College of Chinese Materia Medica and Yunnan Key Laboratory of Southern Medicinal Utilization, Yunnan University of Chinese Medicine, 1076 Yuhua Rd, Chenggong City, Kunming, Yunnan 650500, China.
College of Chinese Materia Medica and Yunnan Key Laboratory of Southern Medicinal Utilization, Yunnan University of Chinese Medicine, 1076 Yuhua Rd, Chenggong City, Kunming, Yunnan 650500, China.
Phytomedicine. 2022 Oct;105:154379. doi: 10.1016/j.phymed.2022.154379. Epub 2022 Aug 3.
The formation of glial scar around the ischemic core following cerebral blood interruption exerts a protective effect in the subacute phase but impedes neurorepair in the chronic phase. Therefore, the present study aimed to explore whether p-hydroxy benzaldehyde (p-HBA), a phenolic compound isolated from Gastrodia elata Blume, can cut the Gordian knot of glial scar and promote brain repair after cerebral ischemia.
The effects of p-HBA on neurorepair were evaluated using a rat model of transient middle cerebral artery occlusion (tMCAO). The motor functions were evaluated by neurobehavioral tests, the pathophysiological processes in the peri-infarct cortex (PIC) were detected by viral-based lineage tracking or immunofluorescence staining, and the putative signaling pathway was analyzed by western blot.
Administration of p-HBA in the acute stage after stroke onset alleviated the motor impairment in tMCAO rats in a time-dependent manner. The corresponding cellular events were inhibition of astrogliosis, facilitating the conversion of reactive astrocytes (RAs) into neurons, and prompting angiogenesis in PIC, thereby protecting the structure of the neurovascular unit (NVU). One of the underlying molecular mechanisms is the activation of the neurogenic switch of the Wnt/β-catenin signaling pathway. Notably, p-HBA only promotes astrocyte-to-neuron conversion in the PIC, and only partial RAs were converted to neurons. This pattern of conversion ensures that the brain structure remains unaltered, and the beneficial role of glial scarring is preserved during the subacute phase after ischemia.
These results provided a potential approach to address the dilemma of glial scarring after brain injury, i.e., the pharmacological promotion of astrocyte-to-neuron conversion in the PIC without interfering with normal brain tissue, which mitigates but does not eliminate the glial scar. Subsequently, the neuron rescue-unfriendly environment is switched to a beneficial reconstruction milieu in PIC, which is conducive to neurorepair. Moreover, p-HBA could be a candidate for pharmacological intervention.
脑血流中断后,缺血核心周围胶质瘢痕的形成在亚急性期发挥保护作用,但在慢性期阻碍神经修复。因此,本研究旨在探讨是否从天麻中分离得到的酚类化合物对-羟基苯甲醛(p-HBA)可以切断胶质瘢痕的难题,促进脑缺血后的脑修复。
采用短暂性大脑中动脉闭塞(tMCAO)大鼠模型评估 p-HBA 对神经修复的影响。通过神经行为学测试评估运动功能,通过病毒谱系追踪或免疫荧光染色检测梗死周边皮层(PIC)中的病理生理过程,通过 Western blot 分析潜在的信号通路。
在卒中发作后的急性期给予 p-HBA 治疗,可使 tMCAO 大鼠的运动障碍呈时间依赖性缓解。相应的细胞事件包括抑制星形胶质细胞增生,促进反应性星形胶质细胞(RAs)向神经元转化,并促进 PIC 中的血管生成,从而保护神经血管单元(NVU)的结构。其潜在的分子机制之一是激活 Wnt/β-catenin 信号通路的神经发生开关。值得注意的是,p-HBA 仅在 PIC 中促进星形胶质细胞向神经元的转化,且只有部分 RAs 转化为神经元。这种转化模式确保了大脑结构保持不变,并且在缺血后亚急性期保留了胶质瘢痕的有益作用。
这些结果为解决脑损伤后胶质瘢痕的困境提供了一种潜在的方法,即在不干扰正常脑组织的情况下,在 PIC 中促进星形胶质细胞向神经元的转化,从而减轻但不消除胶质瘢痕。随后,将神经元挽救不利的环境切换到 PIC 中有利的重建环境,有利于神经修复。此外,p-HBA 可能是一种药物干预的候选药物。